newsfilter
← Latest News
FDA Approved Drugs·

Approval of Nexlizet, Nda #211617 (Efficacy)

Approval Date: 11/21/2025; Drug Name: Nexlizet, Nda #211617; Active Ingredients: BEMPEDOIC ACID; EZETIMIBE; Company: Esperion Theraps Inc; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 211617

Company
ESPERION THERAPS INC
Keywords
ESPERION THERAPS INC